Displaying 1 - 12 of 30
Metabolism, Alcohol & Toxicity

GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: Reducing the burden of liver disease - new evidence revealed (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

MAFLD in Focus: Unveiling Insights from RELIEF Study - Insight from APASL 2024

Webcasts
View
Metabolism, Alcohol & Toxicity

Metabolic and toxic liver damage in focus - MANPOWER's Latest Breakthroughs Revealed.

Webcasts
View
Metabolism, Alcohol & Toxicity

Shedding light on genomic, metabolic, and phenotypic effects of essential phospholipids on HepaRG

Webcasts
View
Metabolism, Alcohol & Toxicity

Metabolic Comorbidities Unmasked -  Redefining MASLD/MASH Impact

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Setting the scene: from NASH to MASH and beyond

Webcasts
View
Metabolism, Alcohol & Toxicity

Boehringer Ingelheim: MASH in focus: novel insights on diagnosis, management and coordinated patient care (Complete Session)

Webcasts
View
Displaying 1 - 12 of 30